A PI3K inhibitor, LY294002, was reported to synergize with an IAP antagonist in non-small cell lung carcinoma (NSCLC) H1299 cells via suppression of cIAP2 induction47. This evidence concerns the gene BIRC3 and non-small cell lung carcinoma.